Updated: 3-23-26 @ 15:33
A bill addressing the use of psilocybin for post-traumatic stress disorder has advanced in the Iowa House.
According to “The View from Here,” a newsletter from state Senator Dennis Guth, a Republican from Klemme, House File 620 moved through both subcommittee and full committee last week. The proposal focuses on allowing the production and supervised administration of psilocybin, a psychedelic compound found in certain mushrooms, for individuals diagnosed with PTSD.
Under the bill, patients would receive treatment in a controlled setting with a licensed counselor present for the duration of the session, which could last up to six hours.
Guth noted that because psilocybin remains a federally restricted substance, research is still limited. However, he said some states that have implemented similar programs have reported reductions in the effects of PTSD following treatment.
_______________________________________________________________________________________________________________________________________________
Original story:
A bill addressing the use of psilocybin for post-traumatic stress disorder has advanced in the Iowa House.
According to “The View from Here,” a newsletter from state Rep. Dennis Guth, a Republican from Klemme, House File 620 moved through both subcommittee and full committee last week. The proposal focuses on allowing the production and supervised administration of psilocybin, a psychedelic compound found in certain mushrooms, for individuals diagnosed with PTSD.
Under the bill, patients would receive treatment in a controlled setting with a licensed counselor present for the duration of the session, which could last up to six hours.
Guth noted that because psilocybin remains a federally restricted substance, research is still limited. However, he said some states that have implemented similar programs have reported reductions in the effects of PTSD following treatment.
